Aging-associated changes in hematopoiesis and leukemogenesis: What's the connection?

Aging

Volumn 3, Issue 6, 2011, Pages 643-656

  Henry, Curtis J ^a   Marusyk, Andriy ^b   DeGregori, James ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; CELL TRANSFORMATION; GENETICS; HEMATOPOIESIS; HUMAN; INNATE IMMUNITY; LEUKEMIA; MOLECULAR EVOLUTION; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCTIVE FITNESS; REVIEW;

AGING; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EVOLUTION, MOLECULAR; GENETIC FITNESS; HEMATOPOIESIS; HUMANS; IMMUNITY, INNATE; LEUKEMIA; MUTATION;

EID: 80055110647     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100351     Document Type: Article

References (113)

1. Dorshkind K, Montecino-Rodriguez E, Signer RA: The ageing immune system: is it ever too old to become young again? Nat Rev Immunol 2009, 9(1):57-62.
2. Rossi DJ, Bryder D, Weissman IL: Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol 2007, 42(5):385-390.
3. Benz CC, Yau C: Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer 2008, 8(11):875-879.
4. Blagosklonny MV, Campisi J, Sinclair DA, Bartke A, Blasco MA, Bonner WM, Bohr VA, Brosh RM, Jr., Brunet A, Depinho RA et al: Impact papers on aging in 2009. Aging (Albany NY), 2(3):111-121.
5. DePinho RA: The age of cancer. Nature 2000, 408(6809):248-254.
6. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG: Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002, 94(10):2766-2792.
7. Balducci L, Beghe C: Cancer and age in the USA. Crit Rev Oncol Hematol 2001, 37(2):137-145.
8. Nowell PC: The clonal evolution of tumor cell populations. Science 1976, 194(4260):23-28.
9. Sieber OM, Tomlinson SR, Tomlinson IP: Tissue, cell and stage specificity of (epi)mutations in cancers. Nat Rev Cancer 2005, 5(8):649-655.
10. Fleenor CJ, Marusyk A, DeGregori J: Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape. Cell Cycle 2010, 9(15):3005-3011.
11. Degregori J: Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res 2011, 71(11):3739-3744.
12. Greaves M: Cancer stem cells: back to Darwin? Semin Cancer Biol 2010, 20(2):65-70.
13. Merlo LM, Pepper JW, Reid BJ, Maley CC: Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006, 6(12):924-935.
14. Serrano M, Blasco MA: Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol 2007, 8(9):715-722.
15. Blagosklonny MV: Oncogenic resistance to growth-limiting conditions. Nat Rev Cancer 2002, 2(3):221-225.
16. Marusyk A, DeGregori J: Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim Biophys Acta 2008, 1785(1):1-11.
17. Anisimov VN: Carcinogenesis and aging 20 years after: escaping horizon. Mech Ageing Dev 2009, 130(1-2):105-121.
18. Chambers SM, Goodell MA: Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 2007, 3(3):201-211.
19. Peto J: Cancer epidemiology in the last century and the next decade. Nature 2001, 411(6835):390-395.
20. Kirkwood TB: Understanding the odd science of aging. Cell 2005, 120(4):437-447.
21. Chidgey A, Dudakov J, Seach N, Boyd R: Impact of niche aging on thymic regeneration and immune reconstitution. Semin Immunol 2007, 19(5):331-340.
22. Dorshkind K, Swain S: Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol 2009, 21(4):404-407.
23. Weiskopf D, Weinberger B, Grubeck-Loebenstein B: The aging of the immune system. Transpl Int 2009, 22(11):1041-1050.
24. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B: Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008, 46(7):1078-1084.
25. Linton PJ, Dorshkind K: Age-related changes in lymphocyte development and function. Nat Immunol 2004, 5(2):133-139.
26. Sharpless NE, DePinho RA: How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007, 8(9):703-713.
27. Miller JP, Allman D: Linking age-related defects in B lymphopoiesis to the aging of hematopoietic stem cells. Semin Immunol 2005, 17(5):321-329.
28. Warren LA, Rossi DJ: Stem cells and aging in the hematopoietic system. Mech Ageing Dev 2009, 130(1-2):46-53.
29. Yin T, Li L: Fountain of Youth: aged blood-forming stem cells could be rejuvenated by young microenvironment. Cell Res 2010, 20(5):504-505.
30. Kohler A, Schmithorst V, Filippi MD, Ryan MA, Daria D, Gunzer M, Geiger H: Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 2009, 114(2):290-298.
31. Simsek T, Kocabas F, Zheng J, Deberardinis RJ, Mahmoud AI, Olson EN, Schneider JW, Zhang CC, Sadek HA: The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010, 7(3):380-390.
32. Takubo K, Goda N, Yamada W, Iriuchishima H, Ikeda E, Kubota Y, Shima H, Johnson RS, Hirao A, Suematsu M et al: Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010, 7(3):391-402.
33. Eliasson P, Rehn M, Hammar P, Larsson P, Sirenko O, Flippin LA, Cammenga J, Jonsson JI: Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Exp Hematol 2010, 38(4):301-310 e302.
34. Karin M, Lawrence T, Nizet V: Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124(4):823-835.
35. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL: Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447(7145):725-729.
36. Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, Weissman IL: Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A 2005, 102(26):9194-9199.
37. Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman IL, Bryder D, Rossi DJ: Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A 2010, 107(12):5465-5470.
38. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA: Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 2007, 5(8):e201.
39. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL: The aging of hematopoietic stem cells. Nat Med 1996, 2(9):1011-1016.
40. Henry CJ, Marusyk A, Zaberezhnyy V, Adane B, DeGregori J: Declining lymphoid progenitor fitness promotes aging-associated leukemogenesis. Proc Natl Acad Sci U S A 2010, 107(50):21713-21718.
41. Liang Y, Van Zant G, Szilvassy SJ: Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 2005, 106(4):1479-1487.
42. Sudo K, Ema H, Morita Y, Nakauchi H: Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 2000, 192(9):1273-1280.
43. de Haan G, Van Zant G: Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 1999, 93(10):3294-3301.
44. Noda S, Ichikawa H, Miyoshi H: Hematopoietic stem cell aging is associated with functional decline and delayed cell cycle progression. Biochem Biophys Res Commun 2009, 383(2):210-215.
45. Van Zant G, Holland BP, Eldridge PW, Chen JJ: Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice. J Exp Med 1990, 171(5):1547-1565.
46. Chen J, Astle CM, Harrison DE: Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp Hematol 1999, 27(5):928-935.
47. Chen J, Astle CM, Harrison DE: Genetic regulation of primitive hematopoietic stem cell senescence. Exp Hematol 2000, 28(4):442-450.
48. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994, 91(21):9857-9860.
49. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R et al: Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001, 98(7):2043-2051.
50. Guerrettaz LM, Johnson SA, Cambier JC: Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci U S A 2008, 105(33):11898-11902.
51. Muller-Sieburg CE, Cho RH, Karlsson L, Huang JF, Sieburg HB: Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 2004, 103(11):4111-4118.
52. Cho RH, Sieburg HB, Muller-Sieburg CE: A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 2008, 111(12):5553-5561.
53. Challen GA, Boles NC, Chambers SM, Goodell MA: Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 2010, 6(3):265-278.
54. Kent DG, Copley MR, Benz C, Wohrer S, Dykstra BJ, Ma E, Cheyne J, Zhao Y, Bowie MB, Gasparetto M et al: Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential. Blood 2009, 113(25):6342-6350.
55. Ueda Y, Kondo M, Kelsoe G: Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 2005, 201(11):1771-1780.
56. Signer RA, Montecino-Rodriguez E, Witte ON, McLaughlin J, Dorshkind K: Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia. Blood 2007, 110(6):1831-1839.
57. Kuranda K, Vargaftig J, de la Rochere P, Dosquet C, Charron D, Bardin F, Tonnelle C, Bonnet D, Goodhardt M: Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell 2011, 10(3):542-546.
58. Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM: Aging of the innate immune system. Curr Opin Immunol 2010, 22(4):507-513.
59. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908:244-254.
60. Karin M, Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5(10):749-759.
61. Aspinall R, Andrew D: Thymic involution in aging. J Clin Immunol 2000, 20(4):250-256.
62. Zediak VP, Maillard I, Bhandoola A: Multiple prethymic defects underlie age-related loss of T progenitor competence. Blood 2007.
63. Caceres W, Cruz-Amy M, Diaz-Melendez V: AIDS-related malignancies: revisited. P R Health Sci J, 29(1):70-75.
64. Pantanowitz L, Michelow P: Review of human immunodeficiency virus (HIV) and squamous lesions of the uterine cervix. Diagn Cytopathol, 39(1):65-72.
65. De Vuyst H, Lillo F, Broutet N, Smith JS: HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008, 17(6):545-554.
66. Heard I, Palefsky JM, Kazatchkine MD: The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004, 9(1):13-22.
67. Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD: Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007, 450(7171):903-907.
68. Dunn GP, Old LJ, Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21(2):137-148.
69. DeNardo DG, Andreu P, Coussens LM: Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev 2010, 29(2):309-316.
70. Soudja SM, Wehbe M, Mas A, Chasson L, de Tenbossche CP, Huijbers I, Van den Eynde B, Schmitt-Verhulst AM: Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice. Cancer Res, 70(9):3515-3525.
71. Signer RA, Montecino-Rodriguez E, Dorshkind K: Aging, B lymphopoiesis, and patterns of leukemogenesis. Exp Gerontol 2007, 42(5):391-395.
72. Min H, Montecino-Rodriguez E, Dorshkind K: Effects of aging on early B- and T-cell development. Immunol Rev 2005, 205:7-17.
73. Van der Put E, Sherwood EM, Blomberg BB, Riley RL: Aged mice exhibit distinct B cell precursor phenotypes differing in activation, proliferation and apoptosis. Exp Gerontol 2003, 38(10):1137-1147.
74. Allman D, Miller JP: The aging of early B-cell precursors. Immunol Rev 2005, 205:18-29.
75. Min H, Montecino-Rodriguez E, Dorshkind K: Effects of aging on the common lymphoid progenitor to pro-B cell transition. J Immunol 2006, 176(2):1007-1012.
76. Stephan RP, Lill-Elghanian DA, Witte PL: Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J Immunol 1997, 158(4):1598-1609.
77. Lescale C, Dias S, Maes J, Cumano A, Szabo P, Charron D, Weksler ME, Dosquet C, Vieira P, Goodhardt M: Reduced EBF expression underlies loss of B cell potential of hematopoietic progenitors with age. Aging Cell 2010.
78. Johnson SA, Rozzo SJ, Cambier JC: Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J Immunol 2002, 168(10):5014-5023.
79. Rawlings DJ, Quan SG, Kato RM, Witte ON: Long-term culture system for selective growth of human B-cell progenitors. Proc Natl Acad Sci U S A 1995, 92(5):1570-1574.
80. Prieyl JA, LeBien TW: Interleukin 7 independent development of human B cells. Proc Natl Acad Sci U S A 1996, 93(19):10348-10353.
81. Weksler ME, Goodhardt M, Szabo P: The effect of age on B cell development and humoral immunity. Springer Semin Immunopathol 2002, 24(1):35-52.
82. Weksler ME, Szabo P: The effect of age on the B-cell repertoire. J Clin Immunol 2000, 20(4):240-249.
83. Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL, Blomberg BB: Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008, 180(8):5283-5290.
84. Johnson SA, Cambier JC: Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity. Arthritis Res Ther 2004, 6(4):131-139.
85. Hoeijmakers JH: DNA damage, aging, and cancer. N Engl J Med 2009, 361(15):1475-1485.
86. Campisi J: Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120(4):513-522.
87. Sahin E, Depinho RA: Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature, 464(7288):520-528.
88. Sharpless NE, DePinho RA: Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004, 113(2):160-168.
89. Sharpless NE, DePinho RA: p53: good cop/bad cop. Cell 2002, 110(1):9-12.
90. Hinkal G, Parikh N, Donehower LA: Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression. PLoS One 2009, 4(8):e6654.
91. Finkel T, Serrano M, Blasco MA: The common biology of cancer and ageing. Nature 2007, 448(7155):767-774.
92. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadinanos J et al: Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469(7328):102-106.
93. Wynford-Thomas D, Bond JA, Wyllie FS, Jones CJ: Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinog 1995, 12(3):119-123.
94. Marusyk A, Wheeler LJ, Mathews CK, DeGregori J: p53 mediates senescence-like arrest induced by chronic replicational stress. Mol Cell Biol 2007, 27(15):5336-5351.
95. Dumble M, Moore L, Chambers SM, Geiger H, Van Zant G, Goodell MA, Donehower LA: The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 2007, 109(4):1736-1742.
96. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM, Weill JC, Blasco MA, Serrano M: "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. Embo J 2002, 21(22):6225-6235.
97. Garcia-Cao I, Garcia-Cao M, Tomas-Loba A, Martin-Caballero J, Flores JM, Klatt P, Blasco MA, Serrano M: Increased p53 activity does not accelerate telomere-driven ageing. EMBO Rep 2006, 7(5):546-552.
98. Signer RA, Montecino-Rodriguez E, Witte ON, Dorshkind K: Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf. Genes Dev 2008, 22(22):3115-3120.
99. Blagosklonny MV: Prevention of cancer by inhibiting aging. Cancer Biol Ther 2008, 7(10):1520-1524.
100. Chiorazzi N, Hatzi K, Albesiano E: B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann N Y Acad Sci 2005, 1062:1-12.
101. Pollyea DA, Kohrt HE, Medeiros BC: Acute myeloid leukaemia in the elderly: a review. Br J Haematol, 152(5):524-542.
102. Ren R: Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005, 5(3):172-183.
103. Vickers M: Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data. Br J Haematol 1996, 94(1):1-4.
104. Pui CH, Relling MV, Downing JR: Acute lymphoblastic leukemia. N Engl J Med 2004, 350(15):1535-1548.
105. Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (eds.): Wintrobe's Clinical Hematology, 11th edn. Philadelphia: Lippincott Williams and Wilkins; 2004.
106. Muller-Sieburg C, Sieburg HB: Stem cell aging: survival of the laziest? Cell Cycle 2008, 7(24):3798-3804.
107. Kim M, Moon HB, Spangrude GJ: Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann N Y Acad Sci 2003, 996:195-208.
108. Ward JM: Background data and variations in tumor rates of control rats and mice. Prog Exp Tumor Res 1983, 26:241-258.
109. Frith CH, Ward JM, Chandra M: The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol 1993, 21(2):206-218.
110. Bagby GC, Fleischman AG: The stem cell fitness landscape and pathways of molecular leukemogenesis. Front Biosci (Schol Ed) 2011, 3:487-500.
111. Vicente-Duenas C, Abollo-Jimenez F, Ruiz-Roca L, Alonso-Escudero E, Jimenez R, Cenador MB, Criado FJ, Cobaleda C, Sanchez-Garcia I: The age of the target cell affects B-cell leukaemia malignancy. Aging (Albany NY) 2010, 2(12):908-913.
112. Greaves M: Leukemogenesis and ageing: 'fit for transformation'? Aging (Albany NY), 3(2):79-80.
113. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA: Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433(7027):760-764.